150
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Individuals with Bipolar Disorder Have a Higher Level of Homocysteine Than Major Depressive Disorder: A Retrospective Chart Review and Observational Study

, , , , , & show all
Pages 2671-2682 | Received 30 Aug 2022, Accepted 04 Nov 2022, Published online: 15 Nov 2022

References

  • Grande I, Berk M, Birmaher B, Vieta E. Bipolar disorder. Lancet. 2016;387(10027):1561–1572. doi:10.1016/S0140-6736(15)00241-X
  • Liu B, Zhang Y, Fang H, Liu J, Liu T, Li L. Efficacy and safety of long-term antidepressant treatment for bipolar disorders - A meta-analysis of randomized controlled trials. J Affect Disord. 2017;223:41–48. doi:10.1016/j.jad.2017.07.023
  • Hirschfeld RM. Differential diagnosis of bipolar disorder and major depressive disorder. J Affect Disord. 2014;169(Suppl 1):S12–S16. doi:10.1016/S0165-0327(14)70004-7
  • Ryles F, Meyer TD, Adan-Manes J, MacMillan I, Scott J. A systematic review of the frequency and severity of manic symptoms reported in studies that compare phenomenology across children, adolescents and adults with bipolar disorders. Int J Bipolar Disord. 2017;5(1):4.
  • Smith AD, Refsum H. Homocysteine, B vitamins, and cognitive impairment. Annu Rev Nutr. 2016;36:211–239.
  • Murray LK, Jadavji NM. The role of one-carbon metabolism and homocysteine in Parkinson’s disease onset, pathology and mechanisms. Nutr Res Rev. 2019;32(2):218–230.
  • Moretti R, Caruso P. The controversial role of homocysteine in neurology: from labs to clinical practice. Int J Mol Sci. 2019;20(1):231.
  • De la Torre-Iturbe S, Vázquez-Roque RA, De la Cruz-López F, Flores G, Garcés-Ramírez L. Dendritic and behavioral changes in rats neonatally treated with homocysteine; A proposal as an animal model to study the attention deficit hyperactivity disorder. J Chem Neuroanat. 2022;119:102057.
  • Shaw PJ. Excitatory amino acid receptors, excitotoxicity, and the human nervous system. Curr Opin Neurol Neurosurg. 1993;6(3):414–422.
  • Klancnik JM, Cuénod M, Gähwiler BH, Jiang ZP, Do KQ. Release of endogenous amino acids, including homocysteic acid and cysteine sulphinic acid, from rat hippocampal slices evoked by electrical stimulation of Schaffer collateral-commissural fibres. Neuroscience. 1992;49(3):557–570. doi:10.1016/0306-4522(92)90226-R
  • Zhang D, Lipton SA. L-homocysteic acid selectively activates N-methyl-D-aspartate receptors of rat retinal ganglion cells. Neurosci Lett. 1992;139(2):173–177. doi:10.1016/0304-3940(92)90545-I
  • Lipton SA, Kim WK, Choi YB, et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA. 1997;94(11):5923–5928. doi:10.1073/pnas.94.11.5923
  • Ramadan E, Basselin M, Rao JS, et al. Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: implications for its efficacy in bipolar disorder. Int J Neuropsychopharmacol. 2012;15(7):931–943. doi:10.1017/S1461145711001003
  • Kolling J, Scherer EB, Siebert C, et al. Severe hyperhomocysteinemia decreases respiratory enzyme and Na(+)-K(+) ATPase activities, and leads to mitochondrial alterations in rat amygdala. Neurotox Res. 2016;29(3):408–418. doi:10.1007/s12640-015-9587-z
  • Hu H, Wang C, Jin Y, et al. Alpha-lipoic acid defends homocysteine-induced endoplasmic reticulum and oxidative stress in HAECs. Biomed Pharmacother. 2016;80:63–72. doi:10.1016/j.biopha.2016.02.022
  • Elsherbiny NM, Sharma I, Kira D, et al. Homocysteine induces inflammation in retina and brain. Biomolecules. 2020;10(3):393. doi:10.3390/biom10030393
  • Wu H, Wang J, Cao M, et al. Effects of homocysteine-induced endoplasmic reticulum protein on endoplasmic reticulum stress, autophagy, and neuronal apoptosis following intracerebral hemorrhage. IBRO Rep. 2020;9:207–217. doi:10.1016/j.ibror.2020.08.004
  • Mill J, Tang T, Kaminsky Z, et al. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet. 2008;82(3):696–711. doi:10.1016/j.ajhg.2008.01.008
  • Sigitova E, Fišar Z, Hroudová J, Cikánková T, Raboch J. Biological hypotheses and biomarkers of bipolar disorder. Psychiatry Clin Neurosci. 2017;71(2):77–103. doi:10.1111/pcn.12476
  • Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015;14(6). doi:10.1186/1475-2891-14-6
  • Halaris A. Inflammation-associated co-morbidity between depression and cardiovascular disease. Curr Top Behav Neurosci. 2017;31:45–70.
  • Cheng Z, Jiang X, Pansuria M, et al. Hyperhomocysteinemia and hyperglycemia induce and potentiate endothelial dysfunction via μ-calpain activation. Diabetes. 2015;64(3):947–959. doi:10.2337/db14-0784
  • Folstein M, Liu T, Peter I, et al. The homocysteine hypothesis of depression. Am J Psychiatry. 2007;164(6):861–867. doi:10.1176/ajp.2007.164.6.861
  • Yapislar H, Aydogan S, Ozüm Ü. Biological understanding of the cardiovascular risk associated with major depression and panic disorder is important. Int J Psychiatry Clin Pract. 2012;16(1):27–32. doi:10.3109/13651501.2011.620127
  • Delport D, Schoeman R, van der Merwe N, et al. Significance of dietary folate intake, homocysteine levels and MTHFR 677 C>T genotyping in South African patients diagnosed with depression: test development for clinical application. Metab Brain Dis. 2014;29(2):377–384. doi:10.1007/s11011-014-9506-7
  • Baek JH, Bernstein EE, Nierenberg AA. One-carbon metabolism and bipolar disorder. Aust N Z J Psychiatry. 2013;47(11):1013–1018. doi:10.1177/0004867413502091
  • Chiarani F, Tramontina JF, Ceresér KM, et al. Homocysteine and other markers of cardiovascular risk during a manic episode in patients with bipolar disorder. Braz J Psychiatry. 2013;35(2):157–160. doi:10.1590/1516-4446-2012-0797
  • Lyu N, Xing G, Yang J, et al. Comparison of inflammatory, nutrient, and neurohormonal indicators in patients with schizophrenia, bipolar disorder and major depressive disorder. J Psychiatr Res. 2021;137:401–408. doi:10.1016/j.jpsychires.2021.03.010
  • Ozdogan MG, Aydin EF, Ustundag MF, Ceyhun HA, Oral E, Bakan E. Homocysteine, chronotype and clinical course in bipolar disorder patients. Nord J Psychiatry. 2020;74(5):340–345. doi:10.1080/08039488.2019.1710250
  • Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health. 1989;79(3):340–349.
  • Yu J, Xue R, Wang Q, Yu H, Liu X. The effects of plasma homocysteine level on the risk of three major psychiatric disorders: a Mendelian randomization study. Front Psychiatry. 2022;13:841429.
  • Vargas HO, Nunes SO, Barbosa DS, et al. Castelli risk indexes 1 and 2 are higher in major depression but other characteristics of the metabolic syndrome are not specific to mood disorders. Life Sci. 2014;102(1):65–71.
  • Ishii I, Kamata S, Ito S, et al. A high-methionine diet for one-week induces a high accumulation of methionine in the cerebrospinal fluid and confers bipolar disorder-like behavior in mice. Int J Mol Sci. 2022;23(2):928.
  • Scott TM, Tucker KL, Bhadelia A, et al. Homocysteine and B vitamins relate to brain volume and white-matter changes in geriatric patients with psychiatric disorders. Am J Geriatr Psychiatry. 2004;12(6):631–638.
  • Karababa İF, Savas SN, Selek S, et al. Homocysteine levels and oxidative stress parameters in patients with adult ADHD. J Atten Disord. 2017;21(6):487–493.
  • Wan L, Li Y, Zhang Z, Sun Z, He Y, Li R. Methylenetetrahydrofolate reductase and psychiatric diseases. Transl Psychiatry. 2018;8(1):242.
  • Lok A, Mocking RJ, Assies J, et al. The one-carbon-cycle and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in recurrent major depressive disorder; influence of antidepressant use and depressive state? J Affect Disord. 2014;166:115–123.
  • Ezzaher A, Mouhamed DH, Mechri A, et al. Hyperhomocysteinemia in Tunisian bipolar I patients. Psychiatry Clin Neurosci. 2011;65(7):664–671.
  • Kevere L, Purvina S, Bauze D, et al. Elevated serum levels of homocysteine as an early prognostic factor of psychiatric disorders in children and adolescents. Schizophr Res Treatment. 2012;2012:373261.
  • Olas B, Kedzierska M, Wachowicz B. Comparative studies on homocysteine and its metabolite-homocysteine thiolactone action in blood platelets in vitro. Platelets. 2008;19(7):520–527.
  • Carluccio MA, Ancora MA, Massaro M, et al. Homocysteine induces VCAM-1 gene expression through NF-kappaB and NAD(P)H oxidase activation: protective role of Mediterranean diet polyphenolic antioxidants. Am J Physiol Heart Circ Physiol. 2007;293(4):H2344–H2354.
  • Assies J, Mocking RJ, Lok A, Ruhé HG, Pouwer F, Schene AH. Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity. Acta Psychiatr Scand. 2014;130(3):163–180.
  • Kaplan P, Tatarkova Z, Sivonova MK, Racay P, Lehotsky J. Homocysteine and mitochondria in cardiovascular and cerebrovascular systems. Int J Mol Sci. 2020;21(20):7698.
  • Morris G, Walder K, McGee SL, et al. A model of the mitochondrial basis of bipolar disorder. Neurosci Biobehav Rev. 2017;74(Pt A):1–20.
  • Won E, Kim YK. An oldie but goodie: lithium in the treatment of bipolar disorder through neuroprotective and neurotrophic mechanisms. Int J Mol Sci. 2017;18(12):2679.
  • Young AH, Juruena MF. The neurobiology of bipolar disorder. Curr Top Behav Neurosci. 2021;48:1–20.
  • Zhou SJ, Zhang LG, Chen HM, et al. Prevalence and clinical-demographic correlates of hyperhomocysteinemia in inpatients with bipolar disorder in a Han Chinese population. Psychiatry Res. 2018;259:364–369.